Loading...
Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer
BACKGROUND: Current methods to identify, classify, and predict tumor behavior mostly rely on histology, immunohistochemistry, and molecular determinants. However, better predictive markers are required for tumor diagnosis and evaluation. Due, in part, to recent technological advancements, metabolomi...
Na minha lista:
| Udgivet i: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941519/ https://ncbi.nlm.nih.gov/pubmed/32729258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1229 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|